Pharmaceutical company payments to Australian doctors reported to Medicines Australia, 2019–22: a cross‐sectional analysis.

This article discusses the payments made by pharmaceutical companies to Australian doctors and healthcare professionals. These payments are typically in the form of consultancy fees, sponsorship for educational events, and coverage of travel and accommodation expenses. The article highlights that Medicines Australia, an industry body representing most pharmaceutical companies, requires its members to disclose the details of these payments. The data from the most recent three years shows that 4.9% of all registered doctors in Australia received payments totaling $33.44 million. The specialties receiving the highest total payments were haematology/oncology, cardiology, and endocrinology. The article emphasizes the need for greater transparency in reporting these payments and encourages doctors to reflect on their relationships with the pharmaceutical industry. [Extracted from the article]